cobas - Roche Diagnostics

More documents

Recommendations

Info

cobas ® 6800/8800 Early Feasibility Trial Assay focus- HEV � Scope: Preliminary evaluation of the HEV assay � Site: Zurich Blood Transfusion Service SRC, Schlieren � Timeframe: May 2012, September/October 2012 � Objectives: Assay Robustness and Specificity � Specimens: HEV positive panels � Configuration: C-trial-Proto 1.2 / 1.3 HEV samples: 2000 from US, about 1500 from Switzerland December 4, 2012 page 12 ©2012 Roche The cobas The ® cobas 6800/8800 ® 6800/8800 Systems Systems and associated and associated assay products assay are products currently are in currently development, in development, and not commercially and not commercially available. available. Performance characteristics are subject Performance to final local characteristics regulatory approval. are subject to final local regulatory approval.
cobas ® 6800/8800 Early Feasibility Trial Some Experiences from the laboratory � Functions: Well, with some characteristics of a prototype � Design: Functional concept, open view on mechanical parts � Usability: Very good � Software: Preliminary user interface December 4, 2012 page 13 ©2012 Roche The cobas ® 6800/8800 Systems and associated assay products are currently in development, and not commercially available. Performance characteristics are subject to final local regulatory approval.
Page 1 and 2: PCR Forum- November 2012 Future Pla
Page 3 and 4: Change Drives Innovation Main facto
Page 5 and 6: cobas ® 6800 System A closer look
Page 8 and 9: The Sample Journey Sample Sample tr
Page 10 and 11: Scalable Throughput Meeting your te
Page 14 and 15: cobas ® 6800/8800 Systems Developm
Page 16: Thank you for your attention. COBAS

cobas - Roche Diagnostics

Create successful ePaper yourself

Delete template?

Save as template?